902 results on '"Pallansch, Mark A."'
Search Results
52. Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description
53. Survey of poliovirus antibodies in Kano, Northern Nigeria
54. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea
55. Efficacy of inactivated poliovirus vaccine in India
56. Interim CDC Guidance for Polio Vaccination for Travel to and from Countries Affected by Wild Poliovirus
57. Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus
58. First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities — May 2014
59. Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination
60. Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
61. Multifacility outbreak of Middle East respiratory syndrome in Taif, Saudi Arabia
62. Molecular Detection and Characterization of Human Enteroviruses
63. An Outbreak of Wild Poliovirus in the Republic of Congo, 2010–2011
64. Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa
65. Trends in the Risk of U.S. Polio Outbreaks and Poliovirus Vaccine Availability for Response
66. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial
67. Health care worker contact with MERS patient, Saudi Arabia
68. Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal
69. Enteroviruses and Parechoviruses
70. Standardized Methods for Detection of Poliovirus Antibodies
71. Poliomyelitis-Related Case-Fatality Ratio in India, 2002-2006
72. Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population
73. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020
74. Infant Deaths Associated with Human Parechovirus Infection in Wisconsin
75. Transmission of Imported Vaccine-Derived Poliovirus in an Undervaccinated Community in Minnesota
76. Enterovirus-Associated Encephalitis in the California Encephalitis Project, 1998-2005
77. An Outbreak of Concurrent Echovirus 30 and Coxsackievirus A1 Infections Associated with Sea Swimming among a Group of Travelers to Mexico
78. A Large Vaccine-Derived Poliovirus Outbreak on Madura Island: Indonesia, 2005
79. Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico
80. Enterovirus Surveillance — United States, 1970-2005
81. Poliovirus Vaccine Shedding among Persons with HIV in Abidjan, Cote d'Ivoire
82. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011
83. Direct Sequencing of SARS-Coronavirus S and N Genes from Clinical Specimens Shows Limited Variation
84. Persistence of Vaccine-Derived Polioviruses among Immunodeficient Persons with Vaccine-Associated Paralytic Poliomyelitis
85. Circulating vaccine-derived polioviruses: current state of knowledge
86. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom
87. Molecular Epidemiology of Wild Poliovirus Transmission
88. Cell-Free Synthesis and Processing of the Proteins of Poliovirus
89. Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease
90. The Mechanism of Poliovirus Eradication
91. Epidemiology
92. Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019–2023
93. Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response
94. Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options
95. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication
96. Sequential Use of Inactivated Poliovirus Vaccine followed by Oral Poliovirus Vaccine in Oman
97. Comparison of a Monoclonal Antibody-Based IgM Capture ELISA with a Neutralization Assay for Assessing Response to Trivalent Oral Poliovirus Vaccine
98. Increased Immunogenicity of Oral Poliovirus Vaccine Administered in Mass Vaccination Campaigns Compared with the Routine Vaccination Program in Jordan
99. Duration of Poliovirus Excretion and Its Implications for Acute Flaccid Paralysis Surveillance: A Review of the Literature
100. Outbreak of Paralytic Poliomyelitis in a Highly Immunized Population in Jordan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.